Results 121 to 130 of about 67,405 (197)

Yellow Fever—More a Policy and Planning Problem than a Biological One

Emerging Infectious Diseases, 2016
Charles H. Calisher, John P. Woodall
doaj   +1 more source

A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine. [PDF]

NPJ Vaccines, 2022
Desai S, Anil K, Potey AV, Sindhu Y, Grappi S, Lapini G, Manney S, Tyagi P, Montomoli E, Poonawalla CS, Kulkarni PS.   +10 more
europepmc   +1 more source

A Systematic Review and a Meta-Analysis of the Yellow Fever Vaccine in the Elderly Population. [PDF]

Vaccines (Basel), 2022
de Abreu AJL, Cavalcante JR, de Araújo Lagos LW, Caetano R, Braga JU.   +4 more
europepmc   +1 more source

Acceptance of yellow fever vaccine in the older traveller: a cohort study. [PDF]

Acta Biomed, 2021
Ferrara P, Masuet-Aumatell C, Ramon-Torrell JM.   +2 more
europepmc   +1 more source

Yellow fever vaccine protects mice against Zika virus infection. [PDF]

PLoS Negl Trop Dis, 2021
Vicente Santos AC, Guedes-da-Silva FH, Dumard CH, Ferreira VNS, da Costa IPS, Machado RA, Barros-Aragão FGQ, Neris RLS, Dos-Santos JS, Assunção-Miranda I, Figueiredo CP, Dias AA, Gomes AMO, de Matos Guedes HL, Oliveira AC, Silva JL.   +15 more
europepmc   +1 more source

Effectiveness of the Local Additional Risk Minimisation Measures for Yellow Fever Vaccine in the United Kingdom: A Survey of Healthcare Professionals and Vaccinees. [PDF]

Pharmacoepidemiol Drug Saf
Karimi L, Luguzis A, Pawar N, Dufournet M, Morelli F, Thollot Y, Guichard MC, Petti G, Li L.   +8 more
europepmc   +1 more source

Anterograde transneuronal tracing and genetic control with engineered yellow fever vaccine YFV-17D. [PDF]

Nat Methods, 2021
Li E, Guo J, Oh SJ, Luo Y, Oliveros HC, Du W, Arano R, Kim Y, Chen YT, Eitson J, Lin DT, Li Y, Roberts T, Schoggins JW, Xu W.   +14 more
europepmc   +1 more source

Yellow Fever Vaccine-Associated Viscerotropic Disease: A Unique Case of Atraumatic Splenic Rupture. [PDF]

Case Rep Infect Dis
Nortey E, Bediako EM, Mould GK, Mills-Annoh A, Ekremet K, Kyei-Baffour P, Ekem A, Clarke JCA, Apaloo EFEK, Quartey-Papafio S.   +9 more
europepmc   +1 more source

Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases. [PDF]

PLoS Negl Trop Dis, 2021
Tonacio AC, do Nascimento Pedrosa T, Borba EF, Aikawa NE, Pasoto SG, Filho JCRF, Sampaio Barros MM, Leon EP, Lombardi SCFS, Junior AM, Azevedo AS, Schwarcz WD, Fuller R, Yuki EFN, Ugolini Lopes MR, Rodrigues Pereira RM, Sampaio Barros PD, de Andrade DCO, de Medeiros-Ribeiro AC, de Moraes JCB, Shinjo SK, Miossi R, da Silva Duarte AJ, Lopes MH, Kallás EG, Almeida da Silva CA, Bonfá E.   +26 more
europepmc   +1 more source

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial. [PDF]

Lancet Infect Dis, 2023
Kimathi D, Juan-Giner A, Orindi B, Grantz KH, Bob NS, Cheruiyot S, Hamaluba M, Kamau N, Fall G, Dia M, Mosobo M, Moki F, Kiogora K, Chirro O, Thiong'o A, Mwendwa J, Guantai A, Karanja HK, Gitonga J, Mugo D, Ramko K, Faye O, Sanders EJ, Grais RF, Bejon P, Warimwe GM.   +25 more
europepmc   +1 more source